EUVIMEDEUVIMED entdecken
Open Access

Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata

Mofreh Mansour, Refaat R Mohamed, Athar Fathy Abodief Mohamed, Mahmoud A Rageh

Dermatology Practical & Conceptual · 31.07.2026 · 16 (3) · 6805

DOI: 10.5826/dpc.1603a6805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 31.07.2026. Verfasst von Mofreh Mansour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, New Damietta, Egypt. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alopecia areata (AA) is a chronic, immune‑mediated, non‑scarring hair loss disorder. While intralesional corticosteroids remain first‑line treatment, some patients with recalcitrant AA respond poorly. Microneedling enhances transdermal drug delivery via microchannel formation. Methotrexate, an established systemic immunomodulator, is effective in resistant AA but has been less extensively studied for topical administration.

Objectives

To compare the efficacy and safety of methotrexate and triamcinolone acetonide, both delivered via microneedling, in recalcitrant AA.

Methods

In this prospective, intra‑individual comparative study, 34 patients with at least two patches of recalcitrant AA received microneedling followed by topical methotrexate (25 mg/mL) on one site and triamcinolone acetonide (5 mg/mL) on a matched site, administered fortnightly for 12 weeks. The primary outcome was the change in Severity of Alopecia Tool (SALT) score. Secondary outcomes included trichoscopic assessment, blinded photographic evaluation, patient satisfaction, and relapse rates at three‑month follow‑up. Safety was assessed at each visit.

Results

Both treatment modalities were associated with overall clinical improvement. Methotrexate‑treated areas showed significantly greater reductions in SALT scores (P

Autor:innen und Institutionen

  • Department of Dermatology, Faculty of Medicine for Girls, Al-Azhar University, New Damietta, Egypt.
  • Department of Dermatology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.
  • Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Zitieren

APA

Mansour, M., Mohamed, R. R., Mohamed, A. F. A., & Rageh, M. A. (2026). Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata. Dermatology Practical & Conceptual, 16(3), 6805. https://doi.org/10.5826/dpc.1603a6805

Vancouver

Mansour M, Mohamed RR, Mohamed AFA, Rageh MA. Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata. Dermatology Practical & Conceptual. 2026;16(3):6805. doi:10.5826/dpc.1603a6805

BibTeX
@article{Mansour2026,
  author = {Mansour, Mofreh and Mohamed, Refaat R and Mohamed, Athar Fathy Abodief and Rageh, Mahmoud A},
  title = {Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata},
  journal = {Dermatology Practical & Conceptual},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {6805},
  doi = {10.5826/dpc.1603a6805}
}
Kostenlos starten →